108 related articles for article (PubMed ID: 428417)
1. Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation.
Benditt DG; Pritchett EL; Wallace AG; Gallagher JJ
Eur J Cardiol; 1979 Apr; 9(4):255-76. PubMed ID: 428417
[No Abstract] [Full Text] [Related]
2. [Induction and termination of ventricular tachycardia by programmed electrical stimulation of heart--a case in which the effect of disopyramide phosphate was confirmed by the stimulation study (author's transl)].
Komatsu C; Ishinaga T; Motoyama M; Marutani K; Teruya H; Nakayama M; Kuno A; Sato Y; Yoshimura S
Kokyu To Junkan; 1981 Feb; 29(2):209-15. PubMed ID: 6789431
[No Abstract] [Full Text] [Related]
3. [Action of injectable disopyramide phosphate in the emergency treatment of ventricular tachycardia].
Valère PE; Guerot C; Castillo Fenoy A; Branvin E; Urbanczyk A; Tricot R
Coeur Med Interne; 1977; 16(2):285-92. PubMed ID: 891126
[No Abstract] [Full Text] [Related]
4. Clinical studies of Norpace (Part IV).
Jutzy RV
Angiology; 1975 Jan; 26(1 Pt 2):138-9. PubMed ID: 803798
[No Abstract] [Full Text] [Related]
5. Clinical studies of Norpace (Part V).
Cook WR
Angiology; 1975 Jan; 26(1 Pt 2):140-1. PubMed ID: 1115401
[No Abstract] [Full Text] [Related]
6. Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.
Rangno RE; Warnica W; Ogilvie RI; Kreeft J; Bridger E
J Int Med Res; 1976; 4(1 Suppl):54-8. PubMed ID: 1026530
[No Abstract] [Full Text] [Related]
7. [Therapy of ventricular tachyarrhythmia with disopyramid phosphate].
Steinbrunn W; Mattmann H; Enrico JF; Engel U
Schweiz Med Wochenschr; 1980 Jun; 110(24):953-7. PubMed ID: 7414314
[TBL] [Abstract][Full Text] [Related]
8. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
Romero-Ayala LC; Soní J
Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
[TBL] [Abstract][Full Text] [Related]
9. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
Meltzer RS; Robert EW; McMorrow M; Martin RP
Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
[TBL] [Abstract][Full Text] [Related]
10. Disopyramide.
Koch-Weser J
N Engl J Med; 1979 Apr; 300(17):957-62. PubMed ID: 431563
[No Abstract] [Full Text] [Related]
11. Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.
Manz M; Steinbeck G; Nitsch J; Lüderitz B
Br Heart J; 1983 Mar; 49(3):222-8. PubMed ID: 6830659
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
Breithardt G; Seipel L; Abendroth RR
J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
[TBL] [Abstract][Full Text] [Related]
13. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
Hulting J; Rosenhamer G
J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
[No Abstract] [Full Text] [Related]
14. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
Dzieglielewski T; Wachowiak A
Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
[No Abstract] [Full Text] [Related]
15. Intravenous disopyramide in myocardial infarction: a haemodynamic study.
Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J
N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia.
Vismara LA; Vera Z; Miller RR; Mason DT
Am J Cardiol; 1977 Jun; 39(7):1027-34. PubMed ID: 326016
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies of Norpace (Part I).
Smith WS
Angiology; 1975 Jan; 26(1 Pt 2):124-31. PubMed ID: 1090212
[No Abstract] [Full Text] [Related]
18. Clinical studies of Norpace. Summarizing remarks.
Fowler NO
Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
[No Abstract] [Full Text] [Related]
19. The hemodynamic effects of Norpace. (Part II).
Willis PW
Angiology; 1975 Jan; 26(1 Pt 2):102-10. PubMed ID: 1115396
[No Abstract] [Full Text] [Related]
20. Congestive heart failure caused by oral disopyramide.
Podrid PJ; Schoeneberger A; Lown B
N Engl J Med; 1980 Mar; 302(11):614-7. PubMed ID: 7351909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
